Skip to main content

Table 2 The protection and mortality rate among vaccinated chicken

From: Efficacy improvement of tri-serotypes vaccine for Salmonella using nanomaterial-based adjuvant in chicken

Groups

No. of birds

No. of diseased/Weeks post-challenge

Diseased/Total

No. of Survival

Total no. of survival

Mortality rate

Protection rate

1st week

2nd week

3rd week

4th week

FNPs-G1

10 (ST)

1

0

0

0

1/10

9

26/30

13.3

86.67

10 (SK)

2

0

0

0

2/10

8

   

10 (SE)

1

0

0

0

1/10

9

   

FCNPs-G2

10 (ST)

2

0

1

0

3/10

7

20/30

33

67

10 (SK)

1

1

1

0

3/10

7

   

10 (SE)

2

1

1

0

4/10

6

   

C.CS-G3

10 (ST)

1

1

0

0

2/10

8

24/30

20

80

10 (SK)

1

1

0

0

2/10

8

   

10 (SE)

1

0

1

0

2/10

8

   

SiNPs-G4*

10 (ST)

1

0

0

0

0/10

10

28/30

6.67

93.33

10 (SK)

1

0

0

0

1/10

9

   

10 (SE)

1

0

0

0

1/10

9

   

V-G5 (+ ve Control)

10 (ST)

1

0

1

0

2/10

8

25/30

16.67

83.33

10 (SK)

1

1

0

0

2/10

8

   

10 (SE)

1

0

0

0

1/10

9

   

C-G6 (control)

10 (ST)

4

3

1

1

9/10

1

9/10

90

10

10 (SK)

3

3

2

1

9/10

1

9/10

90

10

10 (SE)

5

3

1

0

9/10

1

9/10

90

10

  1. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001